Background Image
Table of Contents Table of Contents
Previous Page  51 / 76 Next Page
Information
Show Menu
Previous Page 51 / 76 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 6, November/December 2016

AFRICA

381

As was the case in the 20-minute GI model, FTY720 elicited

a much more evident effect when administered at 2.5

µ

M (Fig.

8), showing a profound effect on functional recovery during

reperfusion. Pre-treatment was associated with a reduction in

aortic output (only one heart recovered sufficiently to generate

AO: control: 27.86

±

13.22% vs PreFTY: 0.62%,

n

=

6;

p

<

0.05)

and work recovery (control: 40.74

±

9.98% vs PreFTY: 15.07

±

5.69%,

n

=

6;

p

<

0.05), while reperfusion administration

significantly reduced cardiac output (control: 46.56

±

10.25%

vs PostFTY: 15.02

±

5.38%,

n

=

6;

p

<

0.05) and work recovery

(control: 40.74

±

9.98% vs PostFTY: 11.84

±

4.59%,

n

=

6;

p

<

0.05).

Although reperfusion treatment did not statistically reduce

aortic output recovery, it is noteworthy that of the six hearts

included in the group, only one recovered sufficiently to actually

generate an aortic output. These profound inhibitory effects of

reperfusion-administered FTY720 on post-ischaemic CO and

work are especially intriguing in the light of the increase in CF

shown to be associated with FTY720 administration (Fig. 6).

These combined observations suggest a direct effect of FTY720

on contractility

per se

.

Since 2.5

µ

M FTY720 elicited such a strong detrimental

effect on functional recovery, we also analysed two additional

functional parameters: heart rate and systolic pressure.

Unexpectedly, FTY720 treatment was not associated with a

significant reduction in heart rate recovery (control: 95.00

±

1.85% vs PreFTY: 56.92

±

18.69% and PostFTY: 60.73

±

19.46%,

n

=

6;

p

=

NS) or systolic pressure recovery (control: 84.79

±

2.69% vs PreFTY: 48.89

±

17.03% and PostFTY: 50.96

±

16.58%,

n

=

6;

p

=

NS).

Control

PreFTY PostFTY

Functional recovery (%)

50

40

30

20

10

0

@

Control

PreFTY PostFTY

Functional recovery (%)

60

50

40

30

20

10

0

@

Control

PreFTY PostFTY

Functional recovery (%)

60

50

40

30

20

10

0

@

@

Fig. 8

The effect of 2.5

μ

M FTY720 on functional recovery following 35 minutes’ regional ischaemia (RI) in terms of (A) aortic output,

(B) cardiac output, and (C) total work.

@

p

<

0.05 vs control,

n

=

6.

A

B

C

Control

PreFTY PostFTY

1

μ

m FTY720

Infarct size (% of area at risk)

70

60

50

40

30

20

10

0

p

=

0.0663

@

Control

PreFTY PostFTY

1

μ

m FTY720

Area at risk (% of total area)

60

50

40

30

20

10

0

Control

PreFTY PostFTY

2.5

μ

m FTY720

Infarct size (% of area at risk)

60

50

40

30

20

10

0

@

@

Control

PreFTY PostFTY

2.5

μ

m FTY720

Area at risk (% of total area)

50

40

30

20

10

0

Fig. 9

Effect of FTY720 on infarct size in hearts exposed to 35 minutes of regional ischaemia. At a dose of 1

μ

M (A), FTY720

reduced infarct size when administered at the onset of reperfusion, while pre-ischaemic treatment seemed to aggravate the

ischaemic injury. At a higher dose of 2.5

μ

M, FTY720 however reduced infarct size (C) irrespective whether it was adminis-

tered prior to ischaemia or during early reperfusion. Area at risk, an indication of the ischaemic intervention experimentally

induced did not differ between any of the groups ((B) and (D)).

@

p

<

0.05 vs control,

n

=

6–8.

A

C

B

D